SkinDermic announces very good results of the SDA 001 compound in the treatment of acne.
Paris, December 2nd 2021 SkinDermic is very proud to announce very good results of the SDA 001 compound in the treatment of acne. SDA 001 was evaluated on a prospective, double blind, randomized trial evaluating for 12 weeks SDA 001 versus placebo in patients harboring acne. The results showed a very significant effect in the …
SkinDermic announces very good results of the SDA 001 compound in the treatment of acne. Read More »